“Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors”, J of Skin, vol. 8, no. 1, p. s334, Jan. 2024, doi: 10.25251/skin.8.supp.334.